Microalbuminuria in hypertension: Measurement, variations, interpretation and recommendations;Micro-albuminurie dans l'hypertension arterielle: Mesure, variations, interpretations, recommandations

Archives des Maladies du Coeur et des Vaisseaux

Volumn 93, Issue 11, 2000, Pages 1304-1308

  Hornych, A ^a   Marre, M ^b   Mimran, A ^c   Chaignon, M ^d   Asmar, R ^e   Fauvel, J P ^f,g  

^a HÔPITAL BROUSSAIS   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c LAPEYRONIE HOSPITAL   (France)

^d FOCH HOSPITAL   (France)

^e Institut Cardiovasculaire   (France)

^f EDOUARD HERRIOT HOSPITAL   (France)

^g Groupe d'Evaluation de la Societe Francaise d'Hypertension Arterielle de la Mesure   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE;

CARDIOVASCULAR RISK; CREATININE BLOOD LEVEL; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MICROALBUMINURIA; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; SCREENING;

ALBUMINURIA; CARDIOVASCULAR DISEASES; HUMANS; HYPERTENSION; KIDNEY DISEASES; PREVALENCE; RISK FACTORS;

EID: 0033637435     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Increased urinary albumin excretion rate in benign essential hypertension
2. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus
3. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes
4. 1999 World Health Organisation International Society of Hypertension Guidelines for the Management of Hypertension
5. Microalbuminuria as a predictor of vascular disease in non diabetic subjects. Islington diabetes survey
6. Consensus statement
7. Predictive value of testing random urine sample to detect micraalbuminuria in diabetic subjects during outpatient visit
8. Albuminuria in normals and essential hypertension
9. Prevalence and clinical correlates of microalbuminuria in essential hypertension
10. Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: The Hoorn Study
11. Effects of storage time and temperature on measurement of small concentrations of albumin in urine
12. Radioimmunoassay for urinary albumin using a single antibody
13. Laser immunonephelometry for routine quantification of urinary albumin excretion
14. Enzyme immunoassay - An improved determination of urinary albumin in diabetics with incipient nephropathy
15. Evaluation of new rapid office test for microalbuminuria and its comparison to fully quantitative radioimmunoassay
16. Detection of potentially reversible diabetic albuminuria. A three-drop agglutination test for urinary albumin at low concentration
17. Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension and normotension
18. Microalbuminurie. Signification et interet
19. Microalbuminuria and endothelial dysfunction in essential hypertension
20. Microalbuminuria in elderly hypertensives: Reproducibility and relation to clinic and ambulatory blood pressure
21. Risk factors for kidney damage in the adult population of Wadena, Minnesota
22. Is microalbuminuria a marker for early intrarenal vascular dysfunction in essential hypertension?
23. Microalbuminuria in normotensives with genetic risk of hypertension
24. Diurnal variation of blood pressure and microalbuminuria in essential hypertension
25. Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors
26. High prevalence of hypertensive retinopathy and coronary heart disease in hypertensive patients with persistent microalbuminuria under short intensive therapy
27. Insulin resistance in microalbuminuric hypertension. Sites and mechanisms
28. Serum homocysteine level and protein intake are related to risk of microalbuminuria: The Hoorn study
29. Microalbuminuria in uncomplicated essential hypertension and its reduction by antihypertensive treatment
30. Microalbuminuria in essential hypertension-reduction by different antihypertensive drugs
31. Microalbuminuria in patients with essential hypertension. Effect of angiotensin converting enzyme inhibitor and of a calcium channel blocker